ABSTRACT
Suit therapies involve the use of garments, which are a kind of dynamic orthosis. [1] Suit therapies are alternative and complementary treatment methods which have been increasingly utilized in the pediatric rehabilitation settings. Although their use has become popular in recent years, scientific evidence supporting their efficacy still remains scarce.
Therapeutic suits were first designed for cosmonauts in the late 1960s to create forces on the body for stabilizing the torso to allow for more fluent and coordinated movement of all limbs to counteract the adverse effects of zero gravity such as muscle atrophy and osteopenia. [2, 3] Therapeutic suits are body splints made of lycra or a kind of elastomeric fabric which has a circumferential base. They are very closefitting and worn next to the skin. The orientation of fabric applies a dynamic correctional force to target body part(s). [4] The fabric exerts a vertically directed load thus serves as a stability vest. The pressure exerted by lycra garment over trunk and thigh was found to be greater in the sitting position followed by standing and sit to stand positions. [5] These suits are assumed to create tension, thereby strengthening the muscles, and the deep pressure at the joints and provide an additional proprioceptive information which enhances body awareness. Since receiving sensory cues during rehabilitation may improve postural control, the proponents of the suit therapy methods have claimed that, once the body and body segments are in a proper alignment, intensive therapy with the suit on enables reeducation of the brain to recognize and form the correct movement of the muscles: The more correct proprioceptive input result in the more proper alignment (Figure 1 ). [6, 7] It has been proposed that these orthotic garments provide stabilization of the trunk, shoulder and pelvis girdle and, thus, improve proximal stability and upper extremity function. [4] They can also improve the movement fluency. [8] Therefore, children with sensory deficits and poor muscle strength including children with neuromotor developmental disorders and hypotonia can benefit from the use of suit therapies. [9] The developers of this kind of orthotic suits have claimed that these suits appear to be most beneficial for children with moderate to severe hypotonia, particularly axial hypotonia, deficits in dynamic stabilization, tone fluctuations, and unpredictable movement control from dyskinesia, moderate-to-severe hypertonia that is compensatory for poor deep sensation, whole body sensory awareness deficits, and some types of sensory integration problems. Severe restricted pulmonary function and refractory cyanosis are absolute contraindications for lycra-based orthosis use while having severe reflux symptoms, uncontrolled epilepsy, cardiovascular circulatory disorders and being diagnosed with diabetes are relative contraindications. [4, 9] High degree of spasticity, hip dislocation or severe scoliosis, hydrocephalus, myopathies, progressive encephalopathies, and psychiatric or behavior disorders have been also defined as contraindications for Adeli suit and TheraSuit exercise protocols. [10, 11] The undesirable effects pertaining to the use of these orthoses are difficulty in donning/doffing, toileting problems such as constipation and urinary leakage, decrease in respiratory function, heat and skin discomfort (e.g. hyperthermia in summer, cyanosis). [7, [12] [13] [14] [15] The existing therapy garments in the literature include Penguin suit, Adeli suit, TheraSuit, full body suit (Kendall-Camp UK Ltd.), dynamic elastomeric fabric orthosis (DEFO), stabilizing pressure input orthosis (SPIO), UpSuit, Second Skin and PediaSuit ( Figure 2) . [4, 6, 7, 10, 12, [16] [17] [18] [19] [20] [21] [22] [23] These suits are dynamic orthoses available in different designs. The designs range from full body suits to smaller garments such as sleeves/gloves and leggings. [3] They may be prescribed for the upper limb, lower limb, or full body. [1] Also, there is extensive variability in the design of orthosis depending on the purpose and the manufacturer. [3, 18, 19] Suit therapy protocols include wearing only the suit or Figure 1 . Mechanism of action of suit therapies (The vicious cycle (picture 1) can be interrupted and incorrect information is replaced by " new" correct information). [6] wearing the suit within an exercise treatment schedule. Adeli suit and TheraSuit include attachment points for straps and bungee cords. Therapist attempt to correct alignment by adjusting the bungee-like cords. TheraSuit is also a part of the TheraSuit Method®, which is based on an intensive and specific exercise program. The TheraSuit Method® utilizes various tools and exercises. Tools utilized during each exercise session consist of the Universal Exercise Unit, vibration and fitness machines, functional cages (the 'monkey cage' uses a system of pulleys and weights to isolate and strengthen specific muscles; and the 'spider cage' uses a belt and bungee cords to either assist upright positioning or practice many other activities that normally would require the support of more therapists) (Figure 3) . [3, 6, 10] Nonetheless, there is no standardized therapy protocol for suit therapies.
Recently, three systematic reviews have been conducted to evaluate the available evidence regarding the effects of suit therapies. [1, 3, 24] In these reviews, the boundaries of what is known and what is not known have been defined; however, clinically relevant factors which allow guidance for reproduction of the intervention in daily practice still remain to be elucidated. Families who have children with moderate-to-severe disabilities are at risk of spending valuable resources on alternative therapies, and professionals should be cautious in encouraging families to pursue alternative techniques in the early phases of research on their efficacy. [3] To provide information for parents and for health professionals, who are frequently asked for advice on the effect of suit therapy for the management of cerebral palsy (CP), we thought it would be helpful to review the available literature and to provide a comprehensive discussion on the clinical aspects of suit therapies for the management of CP. Therefore, we aimed to review the available peer-reviewed reports of suit therapy to evaluate the clinical aspects and effectiveness of suit therapy for CP.
MATERIALS AND METHODS

Protocol and registration
The review protocol, registered on the Prospero database (CRD42018103053), is available http://w w w. Figure 2 . The existing suit types. [4, 6, 9, 14, 18, [20] [21] [22] [23] reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines.
[25]
Eligibility criteria
Criteria for considering studies for this review were based on the PICOS (population, intervention, comparison, outcome, and study) framework as follows: 
Search strategy
A literature search was performed in the PubMed, SCOPUS, Web of Science, and PEDro databases within the period from the establishment of the relevant database through July 2018. Boolean operators of AND and OR were used to combine keywords to ensure that the search was both sensitive and specific. The search strategy was based on Boolean combinations of the search terms "cerebral palsy, lycra, suit, suit therapy, garment, clothing, dynamic elastomeric fabric orthosis, Adeli, TheraSuit, Theratog''. Other potential studies for inclusion were identified by searching the reference lists of all included articles manually. Three additional articles were identified from the reference lists of the relevant articles.
Data collection and analysis
Two investigators independently extracted data regarding the number of participants, age, CP type, GMFCS level, suit type, intervention including dose of suit therapy, outcome measurements, outcomes, adverse effects, funding using a data extraction form. Any disagreement regarding data were resolved by discussion between the two review authors.
The articles were categorized according to their study design: [26, 27] 1. Class I: RCTs 2. Class II: Cohort studies and non-RCTs 3. Class III: Case-control studies 4. Class IV: Single-case studies and case series.
No studies were sufficiently homogeneous to justify useful meta-analysis. Also, the search results showed that current literature regarding the effectiveness of suit therapies for CP contained heterogeneous data, hindering grading the quality of evidence. Therefore, Figure 3 . Spider cage and universal therapy unit. [6] a narrative synthesis approach was used. The data regarding the study subjects (number, age, CP type, GMFCS level), suit type, intervention including dose of suit therapy, outcome measurements, outcomes, and adverse effects were tabulated.
Methodological quality assessment
The method introduced by Furlan, Pennick, Bombardier, and van Tulder [28, 29] was used to evaluate the risk of bias for the assessment of the methodological quality of RCTs. The quality of the study was rated to be "high", when at least 10 of the 12 criteria were met. The quality of the study was identified to be "low", when the study met fewer than six of the criteria. The quality of studies were rated to be "moderate", when six to nine criteria were met. [28] 
RESULTS
Study selection
A total of 375 articles were identified in the PubMed (n=120), Web of Science (n=91), SCOPUS (n=144), and PEDro (n=20). We included studies published in peer-review journals focusing on the efficacy of suit therapies for CP and excluded review articles, duplications, and non-related articles. Once the duplicates were removed, 199 studies remained. Of the remaining articles, 169 were excluded, as they did not meet the inclusion criteria. A total of 30 full-text articles were accessed. Of these, one of them were excluded, as it was a conference abstract. Finally, 29 studies were included in the review (Figure 4 ).
Study characteristics
Types of studies
A total of 29 studies were included of which 10 (34.5%) were Class I, [8, 10, 12, 16, 21, [30] [31] [32] [33] [34] eight were (27.6%) Class II-III, [4, 14, 15, 17, 20, [35] [36] [37] and 11 (37.9%) were Class IV [7, 11, 13, 18, 19, [38] [39] [40] [41] [42] [43] studies. Data regarding the study subjects (number, age, CP type, GMFCS level), suit type, intervention including dose of suit therapy, outcome measurements, outcomes, and adverse effects are presented in Table 1 Included Class IV articles:
• Case report or case series (n=11) • TheraSuit with the elastic bungee cords attached. Control group (n=10)
• ''Controlsuit'' (TheraSuit without the elastic bungee cords)
Azab and Hamed [31] RCT 30
7-9 years
Spastic diplegic NS TheraSuit Experimental group (n=15)
• Received conventional therapy while wearing suit Control group (n=15)
• Received designed exercise on posture correction
Khayatzadeh et al. [32] RCT 36 Mean age 7.78 years Spastic, dystonic, diplegic, tetraplegic I-IV Adeli suit Two hours a day, 5 days a week, for 4 weeks Three groups:
• NDT with the suit on NDT (n=12)
Abd El-Kafy [33] RCT 51 6-8 years
Two hours a day, 5 days a week for 12 weeks Experimetal group 1 (n=16)
• Theratogs with strapping system for lower extremity Experimental group 2 (n=17)
• Theratogs plus solid GRAFO Control group (n=18)
• Traditional PT Kim et al. [21] RCT 17 • SPIO 2-hour group (n=8) (two hours orthosis wear during therapy besides conventional therapy)
• SPIO 6-hour group (n=8) (four hours of orthosis wear in addition to two hours of wear during therapy besides conventional therapy)
Blair et al. [4] Repeated measures case study, cross-over design 24 15 months-14 years Spastic (7), athetosis (5), dystonia (7), ataxia (4), hypotonia (
NS UP suit (no details given, full body suit figure) Garment wear up to 8 hours/day, mean wear time 6.9 hour/day Rennie et al. [15] Repeated measures case study Nicholson et al. [14] Repeated measures case study Flanagan et al. [17] Quasi-experimental (extra strapping system for some children) 10-12 hours per day, 12 weeks Christy et al. [35] Quasi-experimental Degelaen et al. [36] Quasi-experimental Mélo et al. [20] Retrospective cohort Romeo et al. [37] Quasi-experimental design (non-randomized controlled study) Hylton and Allen [7] Case series Cheng and Chan [38] Case report 2
3-4 years
Hypotonic, athetoid CP NS Dynamic pressure garment One hour of adjustment period for first week. Wear time gradually increased to 2.5 hours per day for 9 months (first case) and for 3 month (second case)
Knox [13] Case series (repeated measures case study) Corn et al. [39] Multiple single subject experimental design 4 8-16 years Ataxic hemiplegia, spastic hemiplegia, asymmetrical spastic quadriplegia, spastic quadriplegia NS Second skin upper limb lycra garment with different design Splint wear up to 6.5 hours a day only at school not at home Angilley [19] Single case study Matthews et al. [18] Case report (repeated measures case study) Bailes et al. [11] Case report 2 8 years 3 months, 7 years 11 months Spastic diplegic III TheraSuit with bungee cords TheraSuit method of intensive suit therapy for 4 hours a day, 5 days a week for 3 consecutive weeks Yasukawa and Uronis [40] Case series 2 5 years, 3.6 years Hemiplegic CP, obstetric brachial plexus palsy (OBPP) NS Dynamic movement orthosis (DMO) glove Subjects began to wear DMO for 1-2 hours a day and wear time gradually increased up to 6-7 hours and continued to wear 6-7 hours a day for 6 months Ko et al. [41] Case report (single subject design) Matthews et al. [42] Retrospective cohort (case series) Bailes et al. [12] • GMFM-66 Kim et al. [21] • Gait analysis Giray et al. [34] • [15] • PEDI gait analysis Nicholson et al. [14] • Flanagan et al. [17] • Gait analysis Christy et al. [35] • GMFM-66 Mélo et al. [20] GMFM Before and after each nodule • Improvement at GMFM scores Imrovement was higher in after first modules and continued over time Parent satisfaction
• Not tested Adverse effect
• Not reported None Romeo et al. [37] GMFM Computerized static balance assessment (center of pressure as a measure of trunk control)
At the beginning of the study and 6 months after the study (assessments were performed with and without the suit) At 6 months study group showed better static balance than control group, while there were no differences between groups in terms of GMFM Parent satisfaction
• Difficulty in putting the suit on Adverse effect
• No specific adverse effect • Skin chaffing over joint lines
None The clinical aspects and effectiveness of suit therapies for cerebral palsy [7] Observational results • Skin sensitivity to lycra material None Knox [13] GMFM QUEST Parent questionnaire Pre-intervention, post-intervention • Three participants had improved GMFM scores while one had a reduced score.
Not
• Two participants showed improvement in QUEST score.
• • Cleaning the suit was problematic because it took a day for the suit to became dry after washing
The subject was selected by second skin and glove was provided by second skin
Matthews et al. [18] • 10 meter walking test • VAS scoring of percieved change in gait Bailes et al. [11] • PEDI • GMFM Three-dimensional gait analysis Pre-and post-intervention Matthews et al. [42] Cobb angle 
Types of participants
Age of the children with CP included in RCTs ranged between 3 and 14 years. The sample size of the RCTs ranged from 16 to 51. Among 29 studies, only nine (31.04%) of them included only a specific type of CP. Fourteen (48.28%) of the studies did not report the GMFCS level of the participants.
Types of interventions
Intervention protocols varied among studies. Also, in most of the studies co-interventions varied among individuals (each child's therapeutic program was individualized with the goal of advancing the patient to the next level of function; [21] for instance, some children spent more time than others using the TheraSuit, cage, and weights. [35] Suit designs also differed among studies and varied among study participants in some of the studies. [13, 14] Strapping system design that varied among participants were also detected (a strapping system was individually designed for each child by consensus of the team). [17] Nine (31.03%) of the studies investigated the effect of suit on upper limb function, [4, 7, 8, 13, 14, 16, 19, 39, 40] while 10 of them investigated effects on lower limb function (e.g. gait analysis parameters, balance or walking performance tests). [11, 15, 17, 18, 21, 33, 36, 37, 41, 43] Suit therapy protocols included wearing only the suit or wearing the suit within an exercise treatment schedule. Suit therapy protocols included wearing the suit within exercise treatment schedule in all RCTs and effects of suit therapy protocol, compared to the effects of only exercise treatment schedule. Some of the Class II-IV studies investigated the effects of only wearing the suit (without receiving exercise treatment). [15, 17, 18, 36] In some of the studies, children continued their regular treatment and they only wore suit and received no intervention, while wearing the suit. [13, 14, 37, 38] 
Types of outcome measures
The Gross Motor Function Measure was the most reported outcome. Outcomes mainly consisted of body structure and function and/or activity level outcomes. The evaluation of the effects of suit therapies on participation component of the International Classification of Functioning, Disability, and Health (ICF) are limited. Follow-up points differed among studies. Seventeen (58.62%) of the studies did not report parental satisfaction or adverse effects. Some of the studies immediate effect of suits were assessed immediately after the patients put on the orthosis. [4, 7, 8, 16] Eleven (37.9%) of the identified studies used kinematic assessments to evaluate the effects Table 3 . Methodological quality assessment Elliott et al. [8] Elliott et al. [16] Bailes et al. [12] Azab and Hamed [31] [32] Kim et al. [21] Table to show the methodological quality assessment rating and scoring of the included randomized controlled studies. Y: Yes (criteria achieved). N: No (criteria not achieved). Internal validity criteria refer to characteristics of the study that might be related to selection bias (criteria 1, 2, 9), performance bias (criteria 3, 4, 10, 11), attrition bias (criteria 6, 7), and detection bias (criteria 5, 12). Each criterion should be scored as yes, unclear, or no, where yes indicates the criterion has been met and therefore suggests a low risk of bias. The quality of the study is rated to be "high" when at least 10 of the 12 criteria were met. The quality of the study is identified to be "low" when the study met fewer than 6 of the criteria. The quality of studies are rated to be "moderate" when 6-9 criteria were met. Key to abbreviations: A 1 Was the method of randomization adequately generated? B 2 Was the treatment allocation adequately concealed? C Was the knowledge of all the allocated interventions adequately prevented during the study?
3 Was the patient blinded to the intervention? 4 Was the care provider blinded to the intervention? 5 Was the outcome assessor blinded to the intervention? D Were incomplete outcome data adequately addressed?
6 Was the drop-out rate described and acceptable? 7 Were all randomized participants analyzed in the group in which they were allocated? E 8 Are reports of the study free of suggestion of selective outcome reporting? F Other sources of potential bias.
9 Were the groups similar at baseline regarding the most important prognostic indicators? 10 Were co-interventions avoided or similar? 11 Was the compliance acceptable in all groups? 12 Was the timing of the outcome assessment similar in all groups?
of suits. [8, 11, [14] [15] [16] [17] 21, 31, 33, 36, 43] Kinematic assessment was performed in only one of the high quality RCTs. [33] 
Methodological quality
The methodological quality score of RCTs varied from 4 to 10. Two (20%) of the RCTs were rated to have low methodological quality, five RCTs (50%) were rated to have moderate methodological quality, and three (30%) of them were rated to have high methodological quality ( Table 3 ). Most of the RCTs failed in blinding care providers, patients or assessors, and only 50% of the trials reported adequate concealment of allocation. Co-interventions were not similar in 40% of the RCTs.
Synthesis of results
There is high quality evidence from one RCT showing that full body suit in addition to conventional therapy is beneficial for improving gross motor function in children with diplegic CP. [30] There is high quality evidence from one RCT suggesting that children with diplegic CP at GMFCS level I, II benefit from the use of TheraTogs strapping system plus ground reaction ankle foot orthosis (GRAFO) to improve gait speed, cadence, stride length, hip and knee flexion angles during walking, compared to conventional therapy with and without suit. [33] There is high quality evidence from one RCT showing that vest type suit therapy in addition to conventional therapy result in improvement in the trunk posture of children with diplegic and tetraplegic CP at GMFCS level III-IV. [34] There is moderate quality of evidence from four RCTs showing that suit therapy in addition to conventional therapy yields no significant change in GMFM compared to conventional therapy only in children with diplegic and tetraplegic CP. There is moderate quality of evidence from one RCT suggesting that lycra arm splints provide improvement in attaining movement goals, postural control and compensatory movements. [16] The Class II-III and IV studies support the findings of the Class I studies. None of the studies investigated the feasibility (e.g adherence/compliance), and cost-effectiveness. Eleven of the included studies were funded by orthotic companies. Undesirable or adverse effects pertaining to the use of suit were reported in only 11 of the included studies. The reported undesirable effects were difficulty in donning/doffing, toileting problems such as constipation and urinary leakage, decrease in respiratory function, heat and skin discomfort (e.g. hyperthermia in summer, cyanosis). [7, [12] [13] [14] [15] 
DISCUSSION
In this review, 10 RCTs were identified. The studies are heterogeneous in design, include different outcome measures which are measured at different follow-up times. The studies investigating the effects of such kind of orthoses mainly consist of quasi-experimental designed studies, case reports, and case series. For systematic reviews and metaanalysis, the Cochrane Collaboration and PRISMA guidelines recommends presenting overall quality of evidence using the GRADE-approach (Grading of Recommendations Assessment, Development, and Evaluation). [44] Due to the heterogeneity of included studies, meta-analysis and creating a GRADE table was not possible in the present review. [27] Thus, all conclusions should, thereby, be considered with caution. We detected significant improvements in the proximal stability, gross motor function, and gait from the high quality RCTs. Recently, three systematic reviews have been conducted to evaluate the available evidence regarding the effects of suit therapies. However, current systematic reviews are often limited in their usefulness for guidelines, as they rate risk of bias by studies across outcomes rather than by outcome across studies. [25, 44, 45] 
Patient characteristics
It is not possible to draw firm conclusions regarding the important question which children with CP may benefit more than others from suit therapies due to limited evidence and heterogeneity of the included studies. Only in one study, improvements were more prominent in children with higher motor function (GMFCS levels II and III). [10] However, it seems reasonable that children with diplegic and tetraplegic CP at GMFCS level III-IV are more suitable for suit therapies aiming to improve proximal stability while children with diplegic CP at GMFCS level I, II are more suitable for suit therapies targeting to improve gait and balance.
Treatment characteristics
Additionally, no firm conclusions could be drawn with regard to specific details of suit therapy what may be more or less effective due to the differences among therapeutic suits and the time regimens in which they were implemented. Proceedings from 2011 American Physical Therapy Association Section on Pediatrics Research summit define dose as frequency, intensity, timing, and type of intervention.
[46] Dose of suit therapies are variable. Bailes [46] suggested that dosing parameters relate to the ingredients in intensive suit therapy programs; therefore, describing the specific protocol is crucial while evaluating packaged programs such as suit therapy that consist of multiple ingredients. The frequency of the therapy was reported to be five days a week for three to 12 weeks in the included studies. Timing of suit therapies ranges two hours to 12 hours a day. The intensity, which refers to how hard the child works within the intervention, was not reported in any of the studies. Type of interventions have not been adequately addressed. [46] Only one RCT compared the effects of two-and six-hours daily wear of the vest type suit in addition to conventional therapy and found no difference between the efficacy of two-and sixhours daily wear on the improved trunk posture. The optimal intensity of wear to guarantee efficacy of suit therapy is still uncertain. [24] The results of RCTs with high and moderate quality have shown that wearing suit during treatment is more effective than conventional treatment. Despite reported undesirable effects, feasibility of the suit therapies has not been studied before. No serious adverse effects were reported. However, given the fact that possible side effects were not sufficiently addressed in all of the included studies and limited evidence on positive effects of suit therapies, widespread uncritical use cannot be supported. In addition, none of the studies investigated the cost-effectiveness of suit therapies. [3] Strength and limitations of the study
The main strength of the present review is that it focused on clinical aspects of suit therapies which is useful for guidance for reproduction of the intervention in daily practice and drawing attention to important points that should be considered in the design of future researches. Also, the present review provided a compressive overview on suit therapies by adding recently published articles that have not been assessed previously. Nonetheless, this review has some limitations. It was impossible to give precise guidance on the right target group and best effective therapy protocol due to heterogeneity of the included studies. We used the method introduced by Furlan, Pennick, Bombardier, and van Tulder [28, 29] for the evaluation of the risk of bias to examine the methodological quality of RCTs. However, scales for the assessment of the methodological quality that numerically summarize multiple components into a single number are judged as misleading and unhelpful by the GRADE guidelines. [45] However, due to heterogeneity of the studies, it was not possible to develop a GRADE approach and, therefore, we used a scale that numerically summarize methodological quality assessment to give an overview of the methodological quality of the RCTs evaluating the effects of suit therapies.
Implementing evidence into clinical practice and future research
Randomized-controlled trials are more powerful than others in their ability to answer research questions on the effectiveness of interventions. [47] Systematic reviews only include RCTs to reduce bias. [44] The results from other type of research studies have left unmentioned. As indicated in a recent paper in the British Medical Journal, parachutes reduce the risk of injury after gravitational challenge, although their effectiveness has not been proved in RCTs. [48] Therefore, systematic reviews can define the boundaries of what is known and what is not known. Systematic reviews may be helpful; however, they can never replace sound clinical reasoning. Cerebral palsy is a heterogeneous condition blending motor, sensory, and cognitive disorders, often accompanied by other medical symptoms. It is impossible to make recommendations for the entire group of CPs at different functional levels. [49] Since researchers measure the average responses in the heterogeneous condition of CP, the results of systematic reviews should be interpreted with caution. Systematic reviews can never make individual recommendations for clinical care; rather, they provide a summary of average responses to intervention as reported in systematic literature review. [50] The implementation of evidence into clinical practice and future research is of utmost importance. Suit therapies may be costly and time-consuming. [1, 3] Due to the lack of definitive treatment for CP, it is not surprising that alternative approaches to management arise and attract attention of parents of children with CP. [51] Families who have children with moderate to severe disabilities are at risk of spending valuable resources on alternative therapies. [52] Cerebral palsy is heterogeneous which involves different parts of the brain with different etiologies and pathophysiologies and, thus, it would be surprising to have one therapy be beneficial for everyone with CP. [53] Suit therapies can be implemented in case of appropriate patient selection criteria, a specific neurological need and intended functional outcome. Children at GMFCS level III may have difficulty with functional upright activities in the suit due to their level of impairment and, therefore, suit therapies for improving such function can be beneficial for children at GMFCS level I and II. [54] The benefits from the treatment should be assessed via ICF based outcome measurement. Success of an intervention can be defined as promoting functioning and ease disability. Therefore, the final aim of implementing suit therapies should be improving function and disability. Any therapy, whether complementary or therapeutic, should be evaluated in terms of its effects on body functions and structures, activities, and participation. [53] For the evaluation of outcomes, immediate effect of the suits should be taken into account and the evaluations should be done without suit on. The only significant improvements from the high quality RCTs were in proximal stability, gross motor function and gait. Children with impaired proximal stability and who require trunk control to ease performing everyday activities may benefit from the use of vest type orthotic garment. Children with diplegic CP may benefit from the use of full body suit in addition to conventional therapy to improve gross motor function. Children with diplegic CP at GMFCS level I, II may benefit from the use of strapping system plus GRAFO to improve gait speed, cadence, stride length, and hip and knee flexion angles during walking compared to conventional therapy with and without suit.
In conclusion, in order to obtain gains in the function, it is important to carefully consider intended use, patient selection criteria, and suit type. The issue is about doing the right things with the right child at the right time, as suit therapies are highly individual. [55] Therefore, ONE size does not fit ALL children with CP. To draw a final conclusion on the effects of dynamic elastomeric fabric orthosis vest, further studies including large numbers of children with CP at different functional levels and ages in order to establish impact of this orthosis type in children with CP at different functional levels and ages via subgroup analysis; kinematic assessment of evaluated body segment; and assessment of activity and participation in addition to body structure and function must be conducted.
